|
Video: Compound Annual Growth Rate (CAGR) Definition
|
|
Date |
Open |
High |
Low |
Close |
Volume |
04/19/2024 |
$13.87 |
$14.02 |
$13.26 |
$13.78 |
3.67M | 04/22/2024 |
$13.95 |
$14.31 |
$13.65 |
$14.10 |
2.27M | 04/23/2024 |
$14.17 |
$14.56 |
$14.17 |
$14.25 |
3.22M | 04/24/2024 |
$14.28 |
$14.35 |
$13.74 |
$13.98 |
2.73M | 04/25/2024 |
$13.56 |
$13.98 |
$13.29 |
$13.91 |
3.86M |
|
TG Therapeutics is a commercial stage biopharmaceutical company focused on the acquisition, development and commercialization of treatments for B-cell diseases. In addition to a research pipeline including several investigational medicines, Co. has received approval from the U.S. Food and Drug Administration for BRIUMVI (ublituximab-xiiy) for the treatment of adult patients with relapsing forms of multiple sclerosis, to include clinically isolated syndrome, relapsing-remitting disease, and active secondary progressive disease, in adults. Co. also evaluates products, technologies and companies for in-licensing, partnership, acquisition and/or investment opportunities. | |
|
TG Therapeutics (TGTX) has the following price history information. Looking back at TGTX historical stock prices for the last five trading days, on April 19, 2024, TGTX opened at $13.87, traded as high as $14.02 and as low as $13.26, and closed at $13.78. Trading volume was a total of 3.67M shares. On April 22, 2024, TGTX opened at $13.95, traded as high as $14.31 and as low as $13.65, and closed at $14.10. Trading volume was a total of 2.27M shares. On April 23, 2024, TGTX opened at $14.17, traded as high as $14.56 and as low as $14.17, and closed at $14.25. Trading volume was a total of 3.22M shares. On April 24, 2024, TGTX opened at $14.28, traded as high as $14.35 and as low as $13.74, and closed at $13.98. Trading volume was a total of 2.73M shares. On April 25, 2024, TGTX opened at $13.56, traded as high as $13.98 and as low as $13.29, and closed at $13.91. Trading volume was a total of 3.86M shares.
TGTX Historical Stock Prices By Date:
Below, we examine the compound annual growth rate — CAGR for short — of an investment into TG Therapeutics shares, starting with a $10,000 purchase of TGTX, and working forward through the historical stock price information to today.
Growth of $10,000.00
Without Dividends Reinvested
|
Start date: |
04/29/2014 |
|
End date: |
04/25/2024 |
|
Start price/share: |
$5.08 |
|
End price/share: |
$13.91 |
|
Dividends collected/share: |
$0.00 |
|
Total return: |
173.82% |
|
Average Annual Total Return: |
10.60% |
|
Starting investment: |
$10,000.00 |
|
Ending investment: |
$27,379.87 |
|
Years: |
10.00 |
|
|
|
Date |
Close |
04/19/2024 | $13.78 | 04/22/2024 | $14.10 | 04/23/2024 | $14.25 | 04/24/2024 | $13.98 | 04/25/2024 | $13.91 |
|
|